Consistently observed across various HCC PDX models, Western blot analyses demonstrated significant reductions in the levels of phosphorylated forms of FAK (p-FAK) at Tyr397, Tyr407, and Tyr925 upon the Sora/Vino treatment. This evidence concerns the gene PTK2 and hepatocellular carcinoma.